Telbivudine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01265 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 35 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | chronic hepatitis C virus infection | KG + DL |
| 2 | hepatitis B virus infection | KG + DL |
| 3 | HIV infectious disease | KG + DL |
| 4 | hepatitis C virus infection | KG + DL |
| 5 | disorder of phenylalanine metabolism | KG + DL |
| 6 | disorder of tyrosine metabolism | KG + DL |
| 7 | feline acquired immunodeficiency syndrome | KG + DL |
| 8 | simian immunodeficiency virus infection | KG + DL |
| 9 | neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | KG + DL |
| 10 | tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria | KG + DL |
| 11 | teratogenic Pierre Robin syndrome | KG + DL |
| 12 | hepatitis E virus infection | KG + DL |
| 13 | hepatitis, viral, animal | KG + DL |
| 14 | hepatitis A virus infection | KG + DL |
| 15 | Omsk hemorrhagic fever | KG + DL |
| 16 | Kyasanur forest disease | KG + DL |
| 17 | early-onset familial noncirrhotic portal hypertension | KG + DL |
| 18 | hepatopulmonary syndrome | KG + DL |
| 19 | idiopathic copper-associated cirrhosis | KG + DL |
| 20 | hepatoportal sclerosis | KG + DL |
| 21 | primitive portal vein thrombosis | KG + DL |
| 22 | hepatic porphyria | KG + DL |
| 23 | neonatal epileptic encephalopathy due to glutaminase deficiency | KG + DL |
| 24 | semicircular canal dehiscence syndrome | KG + DL |
| 25 | idiopathic bilateral vestibulopathy | KG + DL |
| 26 | inborn disorder of phenylalanin or tyrosine metabolism | KG + DL |
| 27 | genetic otorhinolaryngological malformation | KG + DL |
| 28 | tetrahydrobiopterin metabolic process disease | KG + DL |
| 29 | juvenile nasopharyngeal angiofibroma (disease) | KG + DL |
| 30 | familial nasal acilia | KG + DL |
| 31 | silent sinus syndrome | KG + DL |
| 32 | propylthiouracil embryofetopathy | KG + DL |
| 33 | cleft lip/palate-intestinal malrotation-cardiopathy syndrome | KG + DL |
| 34 | maternal hyperthermia induced birth defects | KG + DL |
| 35 | fetal minoxidil syndrome | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.